FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4296029168> ?p ?o ?g. }

• W4296029168 endingPage "701" @default.
• W4296029168 startingPage "689" @default.
• W4296029168 abstract "A bstract Posttraumatic osteoarthritis (PTOA) is mostly treated via corticosteroid administration, and total joint arthroplasty continues to be the sole effective intervention in severe conditions. To assess the therapeutic potential of CCR2 targeting in PTOA, we used biodegradable microplates (µPLs) to achieve a slow and sustained intraarticular release of the CCR2 inhibitor RS504393 into injured knees and followed joint damage during disease progression. RS504393 - loaded µPLs (RS-µPLs) were fabricated via a template-replica molding technique. A mixture of poly(lactic-co-glycolic acid) (PLGA) and RS504393 was deposited into 20 × 10 μm (length × height) wells in a polyvinyl alcohol (PVA) square-patterned template. After physicochemical and toxicological characterizations, the RS504393 release profile from µPL was assessed in PBS buffer. C57BL/6 J male mice were subjected to destabilization of the medial meniscus (DMM)/sham surgery, and RS-µPLs (1 mg/kg) were administered intraarticularly 1 week postsurgery. Administrations were repeated at 4 and 7 weeks post-DMM. Drug free-µPLs (DF-µPLs) and saline injections were performed as controls. Mice were euthanized at 4 and 10 weeks post-DMM, corresponding to the early and severe PTOA stages, respectively. Knees were evaluated for cartilage structure score (ACS, H&E), matrix loss (safranin O score), osteophyte formation and maturation from cartilage to bone (cartilage quantification), and subchondral plate thickness. The RS-µPL architecture ensured the sustained release of CCR2 inhibitors over several weeks, with ~ 20% of RS504393 still available at 21 days. This prolonged release improved cartilage structure and reduced bone damage and synovial hyperplasia at both PTOA stages. Extracellular matrix loss was also attenuated, although with less efficacy. The results indicate that local sustained delivery is needed to optimize CCR2-targeted therapies. Graphical abstract" @default.
• W4296029168 created "2022-09-17" @default.
• W4296029168 creator A5005678564 @default.
• W4296029168 creator A5014022632 @default.
• W4296029168 creator A5016030888 @default.
• W4296029168 creator A5017254842 @default.
• W4296029168 creator A5029111898 @default.
• W4296029168 creator A5048813972 @default.
• W4296029168 creator A5051183794 @default.
• W4296029168 creator A5061631250 @default.
• W4296029168 creator A5066391504 @default.
• W4296029168 date "2022-09-15" @default.
• W4296029168 modified "2023-09-25" @default.
• W4296029168 title "Sustained inhibition of CC-chemokine receptor-2 via intraarticular deposition of polymeric microplates in post-traumatic osteoarthritis" @default.
• W4296029168 cites W1787999986 @default.
• W4296029168 cites W1972051109 @default.
• W4296029168 cites W2002251686 @default.
• W4296029168 cites W2003370392 @default.
• W4296029168 cites W2011227409 @default.
• W4296029168 cites W2022821707 @default.
• W4296029168 cites W2038773696 @default.
• W4296029168 cites W2059103432 @default.
• W4296029168 cites W2060951121 @default.
• W4296029168 cites W2063314046 @default.
• W4296029168 cites W2076642520 @default.
• W4296029168 cites W2091921078 @default.
• W4296029168 cites W2096734017 @default.
• W4296029168 cites W2103457670 @default.
• W4296029168 cites W2115047691 @default.
• W4296029168 cites W2135028173 @default.
• W4296029168 cites W2136913148 @default.
• W4296029168 cites W2138780833 @default.
• W4296029168 cites W2143559247 @default.
• W4296029168 cites W2163804088 @default.
• W4296029168 cites W2164178045 @default.
• W4296029168 cites W2186274000 @default.
• W4296029168 cites W2284032871 @default.
• W4296029168 cites W2342775867 @default.
• W4296029168 cites W2413666910 @default.
• W4296029168 cites W2467384826 @default.
• W4296029168 cites W2549862600 @default.
• W4296029168 cites W2566792041 @default.
• W4296029168 cites W2590696895 @default.
• W4296029168 cites W2800050045 @default.
• W4296029168 cites W2998576628 @default.
• W4296029168 cites W3036880638 @default.
• W4296029168 cites W3107448764 @default.
• W4296029168 cites W3119517350 @default.
• W4296029168 cites W3143824203 @default.
• W4296029168 cites W3165879471 @default.
• W4296029168 cites W3173173756 @default.
• W4296029168 cites W3195375639 @default.
• W4296029168 cites W3200964862 @default.
• W4296029168 cites W3212525640 @default.
• W4296029168 cites W4206923778 @default.
• W4296029168 cites W4221059583 @default.
• W4296029168 cites W799912760 @default.
• W4296029168 doi "https://doi.org/10.1007/s13346-022-01235-1" @default.
• W4296029168 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36109442" @default.
• W4296029168 hasPublicationYear "2022" @default.
• W4296029168 type Work @default.
• W4296029168 citedByCount "2" @default.
• W4296029168 countsByYear W42960291682023 @default.
• W4296029168 crossrefType "journal-article" @default.
• W4296029168 hasAuthorship W4296029168A5005678564 @default.
• W4296029168 hasAuthorship W4296029168A5014022632 @default.
• W4296029168 hasAuthorship W4296029168A5016030888 @default.
• W4296029168 hasAuthorship W4296029168A5017254842 @default.
• W4296029168 hasAuthorship W4296029168A5029111898 @default.
• W4296029168 hasAuthorship W4296029168A5048813972 @default.
• W4296029168 hasAuthorship W4296029168A5051183794 @default.
• W4296029168 hasAuthorship W4296029168A5061631250 @default.
• W4296029168 hasAuthorship W4296029168A5066391504 @default.
• W4296029168 hasBestOaLocation W42960291681 @default.
• W4296029168 hasConcept C105702510 @default.
• W4296029168 hasConcept C126322002 @default.
• W4296029168 hasConcept C136229726 @default.
• W4296029168 hasConcept C141071460 @default.
• W4296029168 hasConcept C142724271 @default.
• W4296029168 hasConcept C155672457 @default.
• W4296029168 hasConcept C171250308 @default.
• W4296029168 hasConcept C185592680 @default.
• W4296029168 hasConcept C192562407 @default.
• W4296029168 hasConcept C204787440 @default.
• W4296029168 hasConcept C2776164576 @default.
• W4296029168 hasConcept C2777397205 @default.
• W4296029168 hasConcept C2780165375 @default.
• W4296029168 hasConcept C2780550940 @default.
• W4296029168 hasConcept C71924100 @default.
• W4296029168 hasConceptScore W4296029168C105702510 @default.
• W4296029168 hasConceptScore W4296029168C126322002 @default.
• W4296029168 hasConceptScore W4296029168C136229726 @default.
• W4296029168 hasConceptScore W4296029168C141071460 @default.
• W4296029168 hasConceptScore W4296029168C142724271 @default.
• W4296029168 hasConceptScore W4296029168C155672457 @default.
• W4296029168 hasConceptScore W4296029168C171250308 @default.
• W4296029168 hasConceptScore W4296029168C185592680 @default.
• W4296029168 hasConceptScore W4296029168C192562407 @default.

• next